Tag: ercp market research_x000D_

  • Key Trends and Insights into the Endoscopic Retrograde Cholangiopancreatography (ERCP) Market: Growth Rate and Opportunities to 2034

    Key Trends and Insights into the Endoscopic Retrograde Cholangiopancreatography (ERCP) Market: Growth Rate and Opportunities to 2034

    Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

    How has the endoscopic retrograde cholangiopancreatography (ercp) market grown over the years?

    In recent times, the market size of endoscopic retrograde cholangiopancreatography (ERCP) has witnessed a considerable expansion. Forecasts predict that it will escalate from $1.72 billion in 2024 to $1.87 billion in 2025, marking a compound annual growth rate (CAGR) of 8.87%. Factors such as an increase in chronic gastrointestinal diseases, application of ERCP, occurrences of pancreatic cancer, government investments, and a surge in medical tourism have contributed to this historic period growth.

    What Is the forecasted market size and growth rate for the endoscopic retrograde cholangiopancreatography (ercp) market?

    Predictions suggest a robust expansion for the endoscopic retrograde cholangiopancreatography (ERCP) market in the upcoming years, with it reaching a valuation of $2.60 billion in 2029, maintaining a compound annual growth rate (CAGR) of 8.58%. The expected growth during the projection period can be associated with a heightened incidence of gastrointestinal diseases, an increased rate of cancer, a concentrated emphasis on investment inflows, rising occurrences of pancreatic duct issues, and a growing need for endoscopes. Key trends that could shape the growth in the forecast period comprise technological progress, collaborations for research and development, upgradation of healthcare infrastructure, expansion of governmental healthcare provisions, and the introduction of advanced products.

    Get your endoscopic retrograde cholangiopancreatography (ercp) market report here!

    https://www.thebusinessresearchcompany.com/report/endoscopic-retrograde-cholangiopancreatography-ercp-global-market-report

    What are the major factors driving growth in the endoscopic retrograde cholangiopancreatography (ercp) market?

    The surge in gastrointestinal conditions is anticipated to stimulate the expansion of the endoscopic retrograde cholangiopancreatography (ERCP) market in the future. These conditions encompass a wide variety of disorders and diseases impacting the gastrointestinal (GI) tract, such as the mouth, esophagus, stomach, small intestine, large intestine (colon), rectum, anus, and other related organs like the liver, gallbladder, and pancreas. A myriad of factors including changes in diet, an older population demographic, use of antibiotics, lifestyle factors, and environmental impact can explain the growing prevalence of these gastrointestinal conditions. ERCP plays a significant role in treating these patients by offering a less invasive procedure to identify and address problems within the bile and pancreatic ducts, for example, gallstones, strictures, tumors, or infections. Point in case, the American Cancer Society, a non-profit organization based in the US, estimated in January 2024 that roughly 26,890 new stomach cancer cases and around 10,880 deaths are expected from this type of cancer in the United States. Hence, the escalating prevalence of gastrointestinal conditions is contributing to the upward trend in the endoscopic retrograde cholangiopancreatography (ERCP) market’s growth.

    What key areas define the segmentation of the global endoscopic retrograde cholangiopancreatography (ercp) Market?

    The endoscopic retrograde cholangiopancreatography (ERCP) market covered in this report is segmented –

    1) By Product: Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices

    2) By Disease Indication: Gastroesophageal Reflux Disease (GERD), Gastrointestinal Cancer, Barrett’s Esophagus, Bile Duct Diseases, Peptic Ulcer Disease, Crohn’s Disease, Intestinal Pseudo-Obstruction, Ogilvie Syndrome, Other Indications

    3) By Application: Biliary Sphincterotomy, Biliary Dilatation, Biliary Stenting, Pancreatic Sphincterotomy, Pancreatic Duct Dilatation, Pancreatic Duct Stentin

    4) By End User: Hospitals And Clinics, Ambulatory Surgery Centers, Other End Users

    Subsegments:

    1) By Endoscopes: Flexible Endoscopes, Semi-Rigid Endoscopes, High-Resolution Endoscopes

    2) By Endotherapy Devices: Stone Extraction Devices, Balloon Dilatation Catheters, Stents, Biopsy Forceps

    3) By Visualization Systems: High-Definition Visualization Systems, Endoscopic Imaging Systems, Video Endoscopes

    4) By Energy Devices: Electrosurgical Devices, Laser Devices, Argon Plasma Coagulation Systems

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=20770&type=smp

    What are the top market players propelling the growth of the endoscopic retrograde cholangiopancreatography (ercp) industry?

    Major companies operating in the endoscopic retrograde cholangiopancreatography (ERCP) market are Medtronic plc, Fujifilm Holdings Corporation, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Ottomed Endoscopy, W. L. Gore & Associates Inc., Streis plc, Cook Group, KARL STORZ SE & Co. KG, CONMED Corporation, PENTAX Medical Inc., AMBU Inc., Samsung Medison Co. Ltd., Medi-Globe GmbH, Telemed System Inc., Micro-Tech Endoscopy Inc., Hobbs Medical Inc., Shaili Endoscopy Pvt. Ltd.

    How are evolving market trends shaping endoscopic retrograde cholangiopancreatography (ercp) Strategies?

    Major companies operating in the ERCP market are focusing on developing innovative technologies, such as the cholangioscope direct visualisation system, to provide advanced, high-resolution direct visualisation of the bile and pancreatic ducts. The cholangioscope direct visualization system is a medical device that provides advanced, high-resolution imaging of the bile and pancreatic ducts during ERCP procedures. For instance, in July 2024, Penlon Limited, a UK-based medical device company, launched the VedVision Cholangioscope Direct Visualisation System, an advanced medical device designed for high-resolution, direct visualization of the bile and pancreatic ducts, enhancing diagnosis and therapeutic intervention during ERCP procedures. It features a 2 mm accessory channel and a dedicated guidewire channel for secure access, supported by a full range of accessories such as biopsy forceps, stone extraction baskets, cytology brushes, and polypectomy snares.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20770

    What regions are dominating the endoscopic retrograde cholangiopancreatography (ercp) market growth?

    North America was the largest region in the endoscopic retrograde cholangiopancreatography (ERCP) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endoscopic retrograde cholangiopancreatography (ERCP) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Endoscopic Camera Global Market Report 2025

    https://thebusinessresearchcompany.com/report/endoscopic-camera-global-market-report

    Pancreatic Cancer Drugs Global Market Report 2025

    https://thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-global-market-report

    Global Pancreatic Cancer Drugs Global Global Market Report 2025

    https://thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-market

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Growth Opportunities and Trends in the Endoscopic Retrograde Cholangiopancreatography (ERCP) Market: Key Insights for 2025-2034

    Growth Opportunities and Trends in the Endoscopic Retrograde Cholangiopancreatography (ERCP) Market: Key Insights for 2025-2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How Will the CAGR of the Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Influence Its Overall Growth by 2034?

    In recent times, the market size for endoscopic retrograde cholangiopancreatography (ERCP) has seen substantial growth. It’s projected to escalate from $1.72 billion in 2024 to $1.87 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.87%. The notable growth witnessed in the past can be credited to factors such as the escalating occurrence of diverse chronic gastrointestinal disorders, increased usage of ERCP, a surge in pancreatic cancer cases, significant government investments in healthcare, and the upward trend in medical tourism.

    The market for endoscopic retrograde cholangiopancreatography (ERCP) is set for vigorous expansion in the coming years, expected to reach $2.60 billion in 2029, at a compound annual growth rate (CAGR) of 8.58%. This expected growth can be credited to the rising cases of gastrointestinal issues, an increase in cancer incidences, augmented focus on investment, a growing number of pancreatic duct occurrences, and a boosted demand for endoscopes. Key trends during this forecast period are expected to be technological enhancements, strategic partnerships for research and development, bolstering of healthcare infrastructure, expansion of governmental healthcare, and the creation of advanced products.

    Which Macro and Microeconomic Factors Are Accelerating the Growth of the Endoscopic Retrograde Cholangiopancreatography (ERCP) Market?

    The rise in gastrointestinal conditions is predicted to spur the expansion of the endoscopic retrograde cholangiopancreatography (ERCP) market. These conditions pertain to various disorders or diseases that impact the gastrointestinal (GI) tract including parts like the mouth, esophagus, stomach, small and large intestine, rectum, and anus. This can also incorporate accessory organs such as the liver, gallbladder, and pancreas. Factors such as dietary modifications, an aging populace, the use of antibiotics, lifestyle factors, and environmental influences contribute to the increased occurrence of gastrointestinal conditions. ERCP offers a less invasive technique to diagnose and treat complications within the bile and pancreatic ducts, like gallstones, strictures, tumors, or infections, benefiting patients with gastrointestinal conditions. For example, the American Cancer Society, a non-profit organization based in the USA, estimated in January 2024 that there will be around 26,890 new cases of stomach cancer along with approximately 10,880 deaths anticipated from this cancer type in the United States. Consequently, the rising prevalence of gastrointestinal conditions is fueling the growth of the endoscopic retrograde cholangiopancreatography (ERCP) market.

    Request Your Free Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Report Sample Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=20770&type=smp

    Who Are the Leading Companies Pioneering Change in the Endoscopic Retrograde Cholangiopancreatography (ERCP) Market?

    Major companies operating in the endoscopic retrograde cholangiopancreatography (ERCP) market are:

    • Medtronic plc_x000D_

    • Fujifilm Holdings Corporation_x000D_

    • Siemens Healthineers AG_x000D_

    • Stryker Corporation_x000D_

    • Boston Scientific Corporation_x000D_

    What Are the Most Significant Trends Transforming the Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Today?

    Leading entities in the ERCP market are pivoting their focus towards the invention of novel technologies like the cholangioscope direct visualisation system. This particular system is a pioneering medical product that offers superior, detailed imaging of the bile and pancreatic ducts in high resolution during ERCP procedures. For instance, Penlon Limited, a renowned UK-based medical device firm, introduced the VedVision Cholangioscope Direct Visualisation System in July 2024. This sophisticated device is engineered for superior, detailed visualisation of the bile and pancreatic ducts, thus improving diagnosis and therapeutic intervention in ERCP procedures. The product comes equipped with a 2 mm accessory channel and a dedicated guidewire channel for secure access, and is supplemented by a comprehensive accessory kit that includes biopsy forceps, stone extraction baskets, cytology brushes, and polypectomy snares.

    Pre-order Your Report for Quick and Easy Delivery!

    https://www.thebusinessresearchcompany.com/report/endoscopic-retrograde-cholangiopancreatography-ercp-global-market-report

    What Are the Primary Segments of the Endoscopic Retrograde Cholangiopancreatography (ERCP) Market and Their Roles in Growth Dynamics?

    The endoscopic retrograde cholangiopancreatography (ERCP) market covered in this report is segmented –

    1) By Product: Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices

    2) By Disease Indication: Gastroesophageal Reflux Disease (GERD), Gastrointestinal Cancer, Barrett’s Esophagus, Bile Duct Diseases, Peptic Ulcer Disease, Crohn’s Disease, Intestinal Pseudo-Obstruction, Ogilvie Syndrome, Other Indications

    3) By Application: Biliary Sphincterotomy, Biliary Dilatation, Biliary Stenting, Pancreatic Sphincterotomy, Pancreatic Duct Dilatation, Pancreatic Duct Stentin

    4) By End User: Hospitals And Clinics, Ambulatory Surgery Centers, Other End Users

    Subsegments:

    1) By Endoscopes: Flexible Endoscopes, Semi-Rigid Endoscopes, High-Resolution Endoscopes

    2) By Endotherapy Devices: Stone Extraction Devices, Balloon Dilatation Catheters, Stents, Biopsy Forceps

    3) By Visualization Systems: High-Definition Visualization Systems, Endoscopic Imaging Systems, Video Endoscopes

    4) By Energy Devices: Electrosurgical Devices, Laser Devices, Argon Plasma Coagulation Systems

    Which Regions Are Leading the Charge in Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Development?

    North America was the largest region in the endoscopic retrograde cholangiopancreatography (ERCP) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endoscopic retrograde cholangiopancreatography (ERCP) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    How Is the Definition of the Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Impacting Future Growth?

    Endoscopic retrograde cholangiopancreatography (ERCP) is a medical procedure that combines endoscopy and X-ray imaging to diagnose and treat conditions affecting the bile ducts, gallbladder, and pancreas. It involves guiding a flexible, lighted tube (endoscope) through the mouth to the small intestine, allowing physicians to examine these organs and address issues such as blockages or stones.

    Browse Through More Similar Reports By The Business Research Company:

    Endoscopic Camera Global Market Report 2025

    https://thebusinessresearchcompany.com/report/endoscopic-camera-global-market-report

    Pancreatic Cancer Drugs Global Market Report 2025

    https://thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-global-market-report

    Global Pancreatic Cancer Drugs Global Global Market Report 2025

    https://thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-market

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: